The FDA has accused Pinnacle Biologics of creating videos that make it hard for healthcare professionals to “adequately ...

The agency took issue with promotions around Pinnacle Biologics’ medication used in photodynamic therapy to treat certain ...

Concordia International Corp. (NASDAQ: CXRX) revealed that the Food and Drug Administration has approved its premarket approval application (PMA) for its new Photofrin 630 PDT Laser. According to the ...

The US Food and Drug Administration (FDA) says two marketing videos submitted by Pinnacle Biologics make misleading statements about the company's cancer drug Photofrin (porfimer sodium), noting that ...

The levels of other SLs were also evaluated with respect to PDT dose. DHsphingosine-1-phosphate was increased 9.8-fold per unit of PDT dose (Table 1). Although the nominal P-value indicates a ...

Photodynamic therapy with PHOTOFRIN® is a two-stage process requiring administration of both drug and light. The first stage of PDT is the intravenous injection of PHOTOFRIN®. Illumination with ...

Concordia Healthcare Corp, a diverse healthcare company, announced that its subsidiary, Pinnacle Biologics, Inc. (Pinnacle), a biopharmaceutical research and development company specialising in rare ...

"The fast pace at which we have advanced this trial, from FDA approval to investigator training to site initiation, is an indication to us of the medical community's support and need for new ...

Children and adolescents with recurrent or progressive brain tumors will have an opportunity to participate in a new Phase 1 clinical trial conducted by Children's Hospital of Wisconsin and the ...